{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:06:50Z","timestamp":1790626010792,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s11046-012-9612-1","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T11:28:13Z","timestamp":1358854093000},"page":"273-279","source":"Crossref","is-referenced-by-count":33,"title":["Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species"],"prefix":"10.1007","volume":"175","author":[{"given":"Jinqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"9612_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11046-009-9193-9","volume":"168","author":"DT Wilson","year":"2009","unstructured":"Wilson DT, Drew RH, Perfect JR. Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update. Mycopathologia. 2009;168:313\u201327.","journal-title":"Mycopathologia"},{"key":"9612_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08820130600616540","volume":"35","author":"M Koziol-Montewka","year":"2006","unstructured":"Koziol-Montewka M, Magrys A, Paluch-Oles J, Bogut A, Buczynski K, Jablonka S. MPO and cytokines in the serum of cancer patients in the context of Candida colonization and infection. Immunol Invest. 2006;35:167\u201379.","journal-title":"Immunol Invest"},{"key":"9612_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","volume":"16","author":"C Rodloff","year":"2011","unstructured":"Rodloff C, Koch D, Schaumann R. Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res. 2011;16:187\u201395.","journal-title":"Eur J Med Res"},{"key":"9612_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11:142\u201351.","journal-title":"Lancet Infect Dis"},{"key":"9612_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","volume":"38","author":"PG Pappas","year":"2004","unstructured":"Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161\u201389.","journal-title":"Clin Infect Dis"},{"key":"9612_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/dkq479","volume":"66","author":"P Chandrasekar","year":"2011","unstructured":"Chandrasekar P. Management of invasive fungal infections: a role for polyenes. J Antimicrob Chemother. 2011;66:457\u201365.","journal-title":"J Antimicrob Chemother"},{"key":"9612_CR7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1099\/jmm.0.013227-0","volume":"59","author":"RJ Kothavade","year":"2010","unstructured":"Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59:873\u201380.","journal-title":"J Med Microbiol"},{"key":"9612_CR8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1345\/aph.1R020","volume":"46","author":"ND Beyda","year":"2012","unstructured":"Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012;46:1086\u201396.","journal-title":"Ann Pharmacother"},{"key":"9612_CR9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20010","volume":"109","author":"M Bedin","year":"2004","unstructured":"Bedin M, Gaben AM, Saucier C, Mester J. Geldanamycin, an inhibitor of the chaperone activity of hsp90, induces MAPK-independent cell cycle arrest. Int J Cancer. 2004;109:643\u201352.","journal-title":"Int J Cancer"},{"key":"9612_CR10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","volume":"309","author":"LE Cowen","year":"2005","unstructured":"Cowen LE, Lindquist S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science. 2005;309:2185\u20139.","journal-title":"Science"},{"key":"9612_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7164\/antibiotics.23.442","volume":"23","author":"C DeBoer","year":"1970","unstructured":"DeBoer C, Meulman PA, Wnuk RJ, Peterson DH. Geldanamycin, a new antibiotic. J Antibiot (Tokyo). 1970;23:442\u20137.","journal-title":"J Antibiot (Tokyo)"},{"key":"9612_CR12","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts\u2013third edition: approved standard M27\u2013A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts\u2013third edition: approved standard M27\u2013A3. Wayne, PA: CLSI; 2008."},{"key":"9612_CR13","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1128\/AAC.47.10.3252-3259.2003","volume":"47","author":"MS Lionakis","year":"2003","unstructured":"Lionakis MS, Lewis RE, Samonis G, Kontoyiannis DP. Pentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother. 2003;47:3252\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"9612_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.","journal-title":"J Antimicrob Chemother"},{"key":"9612_CR15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/PL00012491","volume":"59","author":"D Picard","year":"2002","unstructured":"Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci. 2002;59:1640\u20138.","journal-title":"Cell Mol Life Sci"},{"key":"9612_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156800907780809778","volume":"7","author":"SC Bishop","year":"2007","unstructured":"Bishop SC, Burlison JA, Blagg BS. Hsp90: a novel target for the disruption of multiple signaling cascades. Curr Cancer Drug Targets. 2007;7:369\u201388.","journal-title":"Curr Cancer Drug Targets"},{"key":"9612_CR17","doi-asserted-by":"crossref","first-page":"35231","DOI":"10.1074\/jbc.M301371200","volume":"278","author":"AS Sreedhar","year":"2003","unstructured":"Sreedhar AS, Mihaly K, Pato B, Schnaider T, Stetak A, Kis-Petik K, et al. Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events. J Biol Chem. 2003;278:35231\u201340.","journal-title":"J Biol Chem"},{"key":"9612_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0703549","volume":"131","author":"M Bucci","year":"2000","unstructured":"Bucci M, Roviezzo F, Cicala C, Sessa WC, Cirino G. Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br J Pharmacol. 2000;131:13\u20136.","journal-title":"Br J Pharmacol"},{"key":"9612_CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48:503\u201335.","journal-title":"Clin Infect Dis"},{"key":"9612_CR20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","volume":"6","author":"A Coste","year":"2007","unstructured":"Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d\u2019Enfert C, et al. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell. 2007;6:1889\u2013904.","journal-title":"Eukaryot Cell"},{"key":"9612_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2:73\u201385.","journal-title":"Lancet Infect Dis"},{"key":"9612_CR22","doi-asserted-by":"crossref","first-page":"e1000471","DOI":"10.1371\/journal.ppat.1000471","volume":"5","author":"LE Cowen","year":"2009","unstructured":"Cowen LE. Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathog. 2009;5:e1000471.","journal-title":"PLoS Pathog"},{"key":"9612_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrmicro1835","volume":"6","author":"LE Cowen","year":"2008","unstructured":"Cowen LE. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol. 2008;6:187\u201398.","journal-title":"Nat Rev Microbiol"},{"key":"9612_CR24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/dkm493","volume":"61","author":"Y Li","year":"2008","unstructured":"Li Y, Sun S, Guo Q, Ma L, Shi C, Su L, et al. In vitro interaction between azoles and cyclosporine A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother. 2008;61:577\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"9612_CR25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.007","volume":"123","author":"LJ Feng","year":"2010","unstructured":"Feng LJ, Wan Z, Wang XH, Li RY, Liu W. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene. Chin Med J (Engl). 2010;123:544\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"9612_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1348-0421.2003.tb02794.x","volume":"47","author":"K Maebashi","year":"2003","unstructured":"Maebashi K, Kudoh M, Nishiyama Y, Makimura K, Kamai Y, Uchida K, et al. Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient. Microbiol Immunol. 2003;47:117\u201324.","journal-title":"Microbiol Immunol"},{"key":"9612_CR27","doi-asserted-by":"crossref","first-page":"34311","DOI":"10.1074\/jbc.M111.264671","volume":"286","author":"S Borah","year":"2011","unstructured":"Borah S, Shivarathri R, Kaur R. The Rho1 GTPase-activating protein Cgbem2 is required for survival of azole stress in Candida glabrata. J Biol Chem. 2011;286:34311\u201324.","journal-title":"J Biol Chem"},{"key":"9612_CR28","doi-asserted-by":"crossref","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","volume":"6","author":"SL LaFayette","year":"2010","unstructured":"LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AA, et al. Pkc signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, Calcineurin, and Hsp90. PLoS Pathog. 2010;6:e1001069.","journal-title":"PLoS Pathog"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9612-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-012-9612-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9612-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T01:24:46Z","timestamp":1714872286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-012-9612-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":28,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9612"],"URL":"https:\/\/doi.org\/10.1007\/s11046-012-9612-1","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}